DEFINITIVE PROXY STATEMENT

Company

SANGAMO THERAPEUTICS, INC

Filed

April 28, 2006

Period of Report

June 7, 2006

Accession Number

0000950149-06-000215

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →